Infectious diseases Point-of-Care (POC) Diagnostic Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis (2017-2021) and Forecast (2022-2028)

$ PRICE - $ 3,000.00$ 8,900.00

Infectious Diseases Point-of-Care (POC) Diagnostic Market: By Component Type (Instruments, Reagents and Kits, Software and Services), By Technology (Lateral Flow Immunoassay, Agglutination Test, Molecular Diagnostics, others), By Disease (HIV, Hospital Acquired Infections, HBV, Respiratory Tract Infections, HPV, HCV, Tuberculosis, COVID-19, Others) By End User (Home Care, Hospitals and Clinics, Diagnostic Laboratories, Academic and Research Institutes, Others) and Geograpy

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail

Report

Description

Infectious Disease Point of Care Diagnostics Market size is valued at USD 2,547.8 million in 2021 and expected to grow at a significant CAGR of 7.2% during the forecast period 2022 to 2028. The global market provides a detailed overview of the Global Infectious Disease Point of Care Diagnostics market and that can be segmented by components, by technique, by disease, and end-user. By components, The global infectious disease point of care diagnostics market has been segmented into Instruments, Reagents and Kits, Software and Services. The instruments segment is likely to be the largest and fastest-growing segment in terms of type. Based on technique, the global infectious disease point of care diagnostics market is segmented into Lateral flow immunoassay, Agglutination test, Molecular Diagnostics, and others.  Among these, the lateral flow immunoassay segment is expected to have the fastest-growing market during the forecast period 2022-2028. By disease, the global infectious disease point of care diagnostics market is segmented into HIV, Hospital Acquired Infections, HBV, Respiratory Tract Infections, HPV, HCV, Tuberculosis, COVID-19, Others. The respiratory tract infections segment accounts for the largest share in 2021. Hospital acquired infections is the second-largest share during the forecast period 2021-2028. Based on the end-user, the market has been segregated into Home Care, Hospitals and Clinics, Diagnostic Laboratories, Academic and Research Institutes, Others. The Hospitals and clinics segment is expected to dominate other segments in the global infectious disease point of care diagnostics market. The home care segment is expected to witness the highest CAGR during the forecast period according to precision business insights.

Key Development:

In April 2021 Chembio Diagnostics, Inc. launched the rapid point-of-care COVID-19/flu A&B test. The test provides results in 15 min.

Infectious Diseases Point-of-Care (POC) Diagnostic Market

MARKET SUMMARY
-
7.2% CAGR
  • Study Period– 2022 – 2028
  • Base Year– 2021
  • CAGR– 7.2%
  • Largest Market– Asia-Pacific
  • Fastest Growing Market– North-America

Infectious Diseases Point-of-Care (POC) Diagnostic

  • The infectious diseases point-of-care (poc) diagnostic market report gives comprehensive outlook on semen analysis across the globe with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa.
  • The infectious diseases point-of-care (poc) diagnostic market report gives historical, current, and future market sizes (US$ Mn) on by components, by technique, by disease, end-user and geography.
Key Players
  • Cepheid Inc.
  • Siemens AG
  • Beckman Coulter, Inc
  • Abbott Laboratories, Inc.
  • Hoffmann La Roche Limited
Infectious Diseases Point-of-Care (POC) Diagnostic Market

Drivers

The key driving forces for the point-of-care infectious disease diagnostics market is to increase in the prevalence of infectious diseases such as HBV, HCV, HAIs, RTI, and others coupled with launch of advanced diagnostic test kits by the market players across the globe. Moreover, outbreak of COVID-19 drastically increased the revenue in 2020 and 2021.


North-America Got Significant Share

Infectious diseases Point-of-Care (POC) Diagnostic Market

North America market is expected to witness highest market share during the forecast period.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East
Infectious Diseases Point-of-Care (POC) Diagnostic Market Segmentation


Location

GEOGRAPHY

Frequently Asked Questions

The Infectious Diseases Point-of-Care (POC) Diagnostic Market is projected to expand at a CAGR of 7.2% during the forecast period.

The major players in the global infectious disease point of care diagnostics market are Cepheid Inc. (Danaher Corporation) (U.S.), Abbott Laboratories, Inc. (U.S.), Hoffmann La Roche Limited (Switzerland), Beckman Coulter, Inc. (U.S.), Siemens AG (Germany), Johnson & Johnson Services, Inc. (U.S.), Instrumentation Laboratory (U.S.), Becton, Dickinson, and Company (U.S.), Alere Inc. (U.S.), Nova Biomedical (U.S.), Thermo Fisher Scientific Inc. (U.S.) and Quidel Corporation (U.S.)

North-America is the fastest-growing region for Infectious Diseases Point-of-Care (POC) Diagnostic Market


Report

Table Of Content

1. Executive Summary
2. Global Infectious Disease Point of Care Diagnostics Market Introduction
2.1. Global Infectious Disease Point of Care Diagnostics Market – Taxonomy
2.2. Global Infectious Disease Point of Care Diagnostics Market –Definitions
2.2.1. By Components
2.2.2. By Technology
2.2.3. By Disease Type
2.2.4. By End User
2.2.5. By Region
3. Global Infectious Disease Point of Care Diagnostics Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Infectious Disease Point of Care Diagnostics Market Dynamic Factors – Impact Analysis
3.6. Global Infectious Disease Point of Care Diagnostics Market – Competition Landscape
3.7. Epidemiology
4. Global Infectious Disease Point of Care Diagnostics Market Analysis, 2017-2021 and Forecast, 2022-2028
4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global Infectious Disease Point of Care Diagnostics Market, By Components, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.1. Instruments
5.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Reagents and Kits
5.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Software and Services
5.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
6. Global Infectious Disease Point of Care Diagnostics Market, By Technology, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.1. Lateral Flow Immunoassay
6.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Agglutination Test
6.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Molecular Diagnostics
6.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
6.4. Others
6.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.4.3. Market Opportunity Analysis
7. Global Infectious Disease Point of Care Diagnostics Market, Disease Type, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.1. HIV
7.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Hospital Acquired Infections
7.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. HBV
7.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
7.4. Respiratory Tract Infections
7.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.5. HPV
7.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.6. HCV
7.6.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.6.3. Market Opportunity Analysis
7.7. Tuberculosis
7.7.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.7.3. Market Opportunity Analysis
7.8. COVID-19
7.8.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.8.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.8.3. Market Opportunity Analysis
7.9. Others
7.9.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.9.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.9.3. Market Opportunity Analysis
8. Global Infectious Disease Point of Care Diagnostics Market, By End User, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.1. Home Care
8.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Hospitals and Clinics
8.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Diagnostic Laboratories
8.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
8.4. Academic and Research Institutes
8.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.4.3. Market Opportunity Analysis
8.5. Others
8.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.5.3. Market Opportunity Analysis
9. Global Infectious Disease Point of Care Diagnostics Market Forecast, By Region, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.1. North America
9.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.1.3. Market Opportunity Analysis
9.2. Europe
9.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.2.3. Market Opportunity Analysis
9.3. Asia-Pacific
9.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.3.3. Market Opportunity Analysis
9.4. Latin America
9.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.4.3. Market Opportunity Analysis
9.5. Middle East and Africa
9.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.5.3. Market Opportunity Analysis
9.6. Global Infectious Disease Point of Care Diagnostics Market – Opportunity Analysis Index, By Components, By Technology, Disease Type, By End User, and Region, 2022-2028
10. North America Infectious Disease Point of Care Diagnostics Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
10.1. Components Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1. Instruments
10.1.2. Reagents and Kits
10.1.3. Software and Services
10.2. Technology Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.2.1. Lateral Flow Immunoassay
10.2.2. Agglutination Test
10.2.3. Molecular Diagnostics
10.2.4. others
10.3. Disease Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.3.1. HIV
10.3.2. Hospital Acquired Infections
10.3.3. HBV
10.3.4. Respiratory Tract Infections
10.3.5. HPV
10.3.6. HCV
10.3.7. Tuberculosis
10.3.8. COVID-19
10.3.9. Others
10.4. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.4.1. Home Care
10.4.2. Hospitals and Clinics
10.4.3. Diagnostic Laboratories
10.4.4. Academic and Research Institutes
10.4.5. Others
10.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.5.1. USA
10.5.2. Canada
10.6. North America Infectious Disease Point of Care Diagnostics Market – Opportunity Analysis Index, By Components, Technology, Disease Type, By End User, and Country, 2022-2028
10.7. North America Infectious Disease Point of Care Diagnostics Market Dynamics – Trends
11. Europe Infectious Disease Point of Care Diagnostics Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
11.1. Components Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Instruments
11.1.2. Reagents and Kits
11.1.3. Software and Services
11.2. Technology Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.2.1. Lateral Flow Immunoassay
11.2.2. Agglutination Test
11.2.3. Molecular Diagnostics
11.2.4. others
11.3. Disease Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.3.1. HIV
11.3.2. Hospital Acquired Infections
11.3.3. HBV
11.3.4. Respiratory Tract Infections
11.3.5. HPV
11.3.6. HCV
11.3.7. Tuberculosis
11.3.8. COVID-19
11.3.9. Others
11.4. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.4.1. Home Care
11.4.2. Hospitals and Clinics
11.4.3. Diagnostic Laboratories
11.4.4. Academic and Research Institutes
11.4.5. Others
11.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.5.1. Germany
11.5.2. UK
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Russia
11.5.7. Rest of Europe
11.6. Europe Infectious Disease Point of Care Diagnostics Market – Opportunity Analysis Index, By Components, Technology, Disease Type, By End User, and Country, 2022-2028
11.7. Europe Infectious Disease Point of Care Diagnostics Market Dynamics – Trends
12. Asia-Pacific Infectious Disease Point of Care Diagnostics Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
12.1. Components Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. Instruments
12.1.2. Reagents and Kits
12.1.3. Software and Services
12.2. Technology Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.2.1. Lateral Flow Immunoassay
12.2.2. Agglutination Test
12.2.3. Molecular Diagnostics
12.2.4. others
12.3. Disease Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.3.1. HIV
12.3.2. Hospital Acquired Infections
12.3.3. HBV
12.3.4. Respiratory Tract Infections
12.3.5. HPV
12.3.6. HCV
12.3.7. Tuberculosis
12.3.8. COVID-19
12.3.9. Others
12.4. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.4.1. Home Care
12.4.2. Hospitals and Clinics
12.4.3. Diagnostic Laboratories
12.4.4. Academic and Research Institutes
12.4.5. Others
12.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.5.1. China
12.5.2. India
12.5.3. Japan
12.5.4. ASEAN
12.5.5. Australia & New Zealand
12.5.6. Rest of Asia-Pacific
12.6. Asia-Pacific Infectious Disease Point of Care Diagnostics Market – Opportunity Analysis Index, By Components, Technology, Disease Type, By End User, and Country, 2022-2028
12.7. Asia-Pacific Infectious Disease Point of Care Diagnostics Market Dynamics – Trends
13. Latin America Infectious Disease Point of Care Diagnostics Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
13.1. Components Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.1. Instruments
13.1.2. Reagents and Kits
13.1.3. Software and Services
13.2. Technology Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.2.1. Lateral Flow Immunoassay
13.2.2. Agglutination Test
13.2.3. Molecular Diagnostics
13.2.4. others
13.3. Disease Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.3.1. HIV
13.3.2. Hospital Acquired Infections
13.3.3. HBV
13.3.4. Respiratory Tract Infections
13.3.5. HPV
13.3.6. HCV
13.3.7. Tuberculosis
13.3.8. COVID-19
13.3.9. Others
13.4. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.4.1. Home Care
13.4.2. Hospitals and Clinics
13.4.3. Diagnostic Laboratories
13.4.4. Academic and Research Institutes
13.4.5. Others
13.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Latin America Infectious Disease Point of Care Diagnostics Market – Opportunity Analysis Index, By Components, Technology, Disease Type, By End User, and Country, 2022-2028
13.7. Latin America Infectious Disease Point of Care Diagnostics Market Dynamics – Trends
14. Middle East and Africa Infectious Disease Point of Care Diagnostics Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
14.1. Components Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.1.1. Instruments
14.1.2. Reagents and Kits
14.1.3. Software and Services
14.2. Technology Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.2.1. Lateral Flow Immunoassay
14.2.2. Agglutination Test
14.2.3. Molecular Diagnostics
14.2.4. others
14.3. Disease Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.3.1. HIV
14.3.2. Hospital Acquired Infections
14.3.3. HBV
14.3.4. Respiratory Tract Infections
14.3.5. HPV
14.3.6. HCV
14.3.7. Tuberculosis
14.3.8. COVID-19
14.3.9. Others
14.4. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.4.1. Home Care
14.4.2. Hospitals and Clinics
14.4.3. Diagnostic Laboratories
14.4.4. Academic and Research Institutes
14.4.5. Others
14.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
14.5.1. Gulf Cooperation Council (GCC) Countries
14.5.2. South Africa
14.5.3. Rest of MEA
14.6. MEA Infectious Disease Point of Care Diagnostics Market – Opportunity Analysis Index, By Components, Technology, Disease Type, By End User, and Country, 2022-2028
14.7. MEA Infectious Disease Point of Care Diagnostics Market Dynamics – Trends
15. Competition Landscape 
15.1. Strategic Dashboard of Top Market Players
15.2. Company Profiles (Introduction, Financial Analysis, Key Components, Key Developments, Strategies, and SWOT Analysis)
15.2.1. Cepheid Inc. (Danaher Corporation) (U.S.)
15.2.2. Abbott Laboratories, Inc. (U.S.)
15.2.3. Hoffmann La Roche Limited (Switzerland)
15.2.4. Beckman Coulter, Inc. (U.S.)
15.2.5. Siemens AG (Germany)
15.2.6. Johnson & Johnson Services, Inc. (U.S.)
15.2.7. Instrumentation Laboratory (U.S.)
15.2.8. Becton, Dickinson and Company (U.S.)
15.2.9. Alere Inc. (U.S.)
15.2.10. Nova Biomedical (U.S.)
15.2.11. Thermo Fisher Scientific Inc. (U.S.)
15.2.12. Quidel Corporation (U.S.)
16. Research Methodology
17. Key Assumptions and Acronyms

Report

Company Profile

  • Cepheid Inc. (Danaher Corporation) (U.S.)
  • Abbott Laboratories, Inc. (U.S.)
  • Hoffmann La Roche Limited (Switzerland)
  • Beckman Coulter, Inc. (U.S.)
  • Siemens AG (Germany)
  • Johnson & Johnson Services, Inc. (U.S.)
  • Instrumentation Laboratory (U.S.)
  • Becton, Dickinson and Company (U.S.)
  • Alere Inc. (U.S.)
  • Nova Biomedical (U.S.)
  • Thermo Fisher Scientific Inc. (U.S.)
  • Quidel Corporation (U.S.)

Description

Infectious Disease Point of Care Diagnostics Market size is valued at USD 2,547.8 million in 2021 and expected to grow at a significant CAGR of 7.2% during the forecast period 2022 to 2028. The global market provides a detailed overview of the Global Infectious Disease Point of Care Diagnostics market and that can be segmented by components, by technique, by disease, and end-user. By components, The global infectious disease point of care diagnostics market has been segmented into Instruments, Reagents and Kits, Software and Services. The instruments segment is likely to be the largest and fastest-growing segment in terms of type. Based on technique, the global infectious disease point of care diagnostics market is segmented into Lateral flow immunoassay, Agglutination test, Molecular Diagnostics, and others.  Among these, the lateral flow immunoassay segment is expected to have the fastest-growing market during the forecast period 2022-2028. By disease, the global infectious disease point of care diagnostics market is segmented into HIV, Hospital Acquired Infections, HBV, Respiratory Tract Infections, HPV, HCV, Tuberculosis, COVID-19, Others. The respiratory tract infections segment accounts for the largest share in 2021. Hospital acquired infections is the second-largest share during the forecast period 2021-2028. Based on the end-user, the market has been segregated into Home Care, Hospitals and Clinics, Diagnostic Laboratories, Academic and Research Institutes, Others. The Hospitals and clinics segment is expected to dominate other segments in the global infectious disease point of care diagnostics market. The home care segment is expected to witness the highest CAGR during the forecast period according to precision business insights.

Key Development:

In April 2021 Chembio Diagnostics, Inc. launched the rapid point-of-care COVID-19/flu A&B test. The test provides results in 15 min.

Reviews

There are no reviews yet.

Be the first to review “Infectious diseases Point-of-Care (POC) Diagnostic Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis (2017-2021) and Forecast (2022-2028)”

Your email address will not be published. Required fields are marked *

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX